University of Pittsburgh researchers find experimental drug could protect some cancer patients from radiation side effects:
Posted Oct 08 2011 11:37pm
University of Pittsburgh researchers find experimental drug could protect some cancer patients from radiation side effects:NCI Cancer Center News
A drug under development at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine could protect the cells of Fanconi anemia patients from damage caused by radiation treatment for head and neck cancers, a new study suggests.
In a separate release, UPCI researchers also announced results of a study that suggests the drug JP4-039 could offer patients protection from radiation-induced esophagitis, an inflammation of the esophagus that causes intense pain during eating and swallowing.
###Among the research institutions NCI funds across the United States, it currently designates 66 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.